Department of Clinical Physics and Bioengineering, University of Glasgow, Gartnavel Royal Hospital, Glasgow G12 0XH, UK.
Ann ICRP. 2020 Dec;49(1_suppl):126-140. doi: 10.1177/0146645320927849. Epub 2020 Nov 4.
The International Commission on Radiological Protection (ICRP) developed effective dose as a quantity related to risk for occupational and public exposure. There was a need for a similar dose quantity linked to risk for making everyday decisions relating to medical procedures. Coefficients were developed to enable the calculation of doses to organs and tissues, and effective doses for procedures in nuclear medicine and radiology during the 1980s and 1990s. Effective dose has provided a valuable tool that is now used in the establishment of guidelines for patient referral and justification of procedures, choice of appropriate imaging techniques, and providing dose data on potential exposure of volunteers for research studies, all of which require the benefits from the procedure to be weighed against the risks. However, the approximations made in the derivation of effective dose are often forgotten, and the uncertainties in calculations of risks are discussed. An ICRP report on protection dose quantities has been prepared that provides more information on the application of effective dose, and concludes that effective dose can be used as an approximate measure of possible risk. A discussion of the way in which it should be used is given here, with applications for which it is considered suitable. Approaches to the evaluation of risk and methods for conveying information on risk are also discussed.
国际辐射防护委员会(ICRP)将有效剂量开发为与职业和公众照射风险相关的量。需要有一种类似的剂量量,与与医疗程序相关的日常决策中的风险联系起来。在 20 世纪 80 年代和 90 年代,制定了系数来计算核医学和放射学程序中器官和组织的剂量以及有效剂量。有效剂量提供了一种有价值的工具,现在用于制定患者转诊和程序正当性的指南、选择适当的成像技术以及提供潜在志愿者的暴露剂量数据,所有这些都需要权衡程序的益处与风险。然而,在推导有效剂量时所做的近似常常被遗忘,并且讨论了风险计算中的不确定性。已经编写了一份关于防护剂量量的 ICRP 报告,该报告提供了有关有效剂量应用的更多信息,并得出结论认为,有效剂量可用作可能风险的近似度量。本文讨论了如何使用它,并给出了认为合适的应用。还讨论了风险评估的方法和风险信息传达的方法。